Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 187
Filter
1.
Biotechnol Lett ; 46(1): 115-126, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38150098

ABSTRACT

Rapid advancements in the field of immunotherapy have significantly improved cancer treatments. Specifically, an individualized cell-based modality which involves the removal of some of the patient's own white blood cells, including T cells, has revolutionized research in this field. This study focuses on the recent advances and current challenges of Chimeric Antigen Receptor- T (CAR-T) cell therapy and its regulations in the United States (US) and European Union (EU). Understanding the regulatory regimes of CAR-T cell therapy is critical for researchers and manufacturers as they navigate the hurdles of bringing CAR-T cell therapy to the global market. Benefits of CAR-T cell therapy include high response rates and the potential of long-term remissions in some haematological malignancies. However, the drawbacks are still evident including high costs, adverse reactions, and limited efficacy to solid tumours. CAR-T cell therapy is rapidly advancing, with 1231 clinical trials launched globally according to www.clinicalTrial.gov . The future of CAR-T cell therapy holds enormous promise but improving its safety, effectiveness, and availability are still barriers to its successful implementation.


Subject(s)
Neoplasms , Receptors, Chimeric Antigen , Humans , Receptors, Antigen, T-Cell/genetics , Immunotherapy, Adoptive/adverse effects , Neoplasms/therapy , Cell- and Tissue-Based Therapy
2.
Scand J Rheumatol ; 51(6): 431-440, 2022 Nov.
Article in English | MEDLINE | ID: mdl-34511031

ABSTRACT

OBJECTIVE: Currently, biological disease-modifying anti-rheumatic drugs (bDMARDs) with different modes of action [tumour necrosis factor inhibitor (TNFi), interleukin-6 receptor inhibitor (IL-6Ri), or cytotoxic T-lymphocyte antigen 4-immunoglobulin (CTLA4-Ig)] are used in clinical practice to treat rheumatoid arthritis (RA). However, it is unclear which type of bDMARD is the most efficacious for a specific clinical situation. C-reactive protein (CRP) is an acute-phase reactant driven by IL-6 signalling. Here, we aimed to establish whether therapeutic efficacy differs between IL-6Ri and other bDMARDs with alternative modes of action in RA patients according to their CRP level. METHOD: RA patients treated with bDMARDs were enrolled from an observational multicentre registry in Japan. Patients were classified into three groups according to baseline CRP tertiles. The overall 3 year retention rates of each bDMARD category were assessed. The Clinical Disease Activity Index (CDAI) was also assessed before and 3, 6, and 12 months after bDMARD initiation. RESULTS: A total of 1438 RA patients were included and classified into three groups according to tertiles of baseline CRP levels (CRP1, 0-0.3; CRP2, 0.3-1.8; CRP3, 1.8-18.4 mg/dL). In CRP3, the overall 3 year drug retention rates were significantly higher for IL-6Ri than for TNFi and CTLA4-Ig (77.5 vs 48.2 vs 67.3, respectively). No significant difference was evident in terms of CDAI 12 months after bDMARD initiation in CRP1-CRP3. CONCLUSION: IL-6Ri may be a favourable therapeutic option over TNFi and CTLA4-Ig in RA patients with high CRP levels.


Subject(s)
Antirheumatic Agents , Arthritis, Rheumatoid , Humans , Abatacept/therapeutic use , Cohort Studies , Arthritis, Rheumatoid/drug therapy , Antirheumatic Agents/therapeutic use , Tumor Necrosis Factor Inhibitors , Antibodies , Treatment Outcome
3.
Tech Coloproctol ; 25(3): 285-289, 2021 03.
Article in English | MEDLINE | ID: mdl-33156413

ABSTRACT

BACKGROUND: The number of abdominal procedures performed via a robotic-assisted approach is increasing as potential advantages of the modality are recognised. We report the first in human case series of major colorectal resection performed using a new system, Versius®, and assess the feasibility of its use. METHODS: The initial cases performed using Versius® at a single centre in the UK were included in the study. Anonymised data were prospectively collected including patient demographics, operative details and postoperative outcomes. RESULTS: Twenty-three operations were performed, including left (n = 14) and right (n = 9)-sided colonic resections. Rectal mobilisation was performed in 13. Fifty-seven percent of the patients were male, with a malignant indication for surgery in 70% of cases. Overall mean age was 59.1 ± 15.3 (range 23-89) years. Overall mean body mass index was 28.9 ± 5.2 with a mean of 31.3 ± 4.5 for left-sided resections. The median console operating time was 166 min (range 75-320 min). All malignant cases had negative resection margins and the mean lymph node yield was 18 (SD 9.4). Only one operation (4%) was converted from robotic to open approach. Postoperative length of stay was a median of 5 days (range 3-34 days) and there were no readmissions within 30 days. CONCLUSIONS: These results compare favourably with the literature on existing robotic systems and also conventional laparoscopic surgery; hence, we believe that this series indicates the Versius® system is feasible for use in major colorectal resection. These early results from a robot-naïve centre show exciting promise for an expanding robotic market and highlight the need for further evaluation.


Subject(s)
Colorectal Neoplasms , Laparoscopy , Robotic Surgical Procedures , Robotics , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/surgery , Female , Humans , Male , Middle Aged , Rectum , Treatment Outcome , Young Adult
4.
Am J Geriatr Psychiatry ; 28(4): 491-494, 2020 04.
Article in English | MEDLINE | ID: mdl-31530457

ABSTRACT

OBJECTIVE: The objective for the current study is to examine patient satisfaction with geropsychiatry services provided via video telehealth. METHODS: Participants included community-dwelling older Veterans receiving geriatric psychiatry services via telehealth across regions of the Pacific Northwest and Southwestern United States. Participants completed a paper-based survey examining satisfaction with services following the completion of two medication management visits with a geropsychiatrist. RESULTS: The majority of participants (90%) reported liking or even preferring geriatric telepsychiatry, despite the experience being novel for the majority of patients. Eighty-three percent of participants reported that receiving telegeropsychiatry services was the same (n = 30) or better (n = 3) than being seen in-person. Participants saved an average of 168 driving miles (means and standard deviations = 59.2; range 2-480) each visit. CONCLUSION: The findings of the current study suggest that older adults accept and are broadly satisfied with telegeropsychiatry services. This modality of care increased access to specialty care and decreased travel hardship.


Subject(s)
Geriatric Psychiatry , Patient Satisfaction/statistics & numerical data , Telecommunications/statistics & numerical data , Aged , Female , Humans , Male , Patient Acceptance of Health Care , Telecommunications/trends
5.
Geriatrics (Basel) ; 4(1)2019 Jan 09.
Article in English | MEDLINE | ID: mdl-31023977

ABSTRACT

After the first fracture, the risk of subsequent fractures increases significantly. Medical treatment can reduce the risk of a second fracture by about 50%, but many older adults do not receive osteoporosis medication following their first fracture. This observational study aimed to understand primary care management patterns of older adults after osteoporotic fractures at the Miami Veterans Affairs (VA) Healthcare System. A retrospective review of 219 fracture cases selected by International Classification of Disease (ICD-9) codes between October 2015 and September 2016 identified 114 individuals age ≥50 years who had a non-traumatic fracture code entered in their medical record for the first time. Among them, 72 (63%) did not undergo a bone mineral density (BMD) test or receive treatment in the 12 months following their fracture. Of the 40 individuals who had a BMD test post-fracture, 17 (100%) received or were considered for anti-osteoporosis treatment if their T-score indicated osteoporosis (T-score ≤-2.5), but only 8/23 (35%) if the T-score was >-2.5. Physicians are more likely to prescribe osteoporosis therapy based on a BMD T-score diagnosis of osteoporosis, rather than a clinical diagnosis of osteoporosis based on a low-trauma fracture. A change in practice patterns is necessary to decrease the incidence of fractures.

7.
Transl Psychiatry ; 5: e639, 2015 Sep 22.
Article in English | MEDLINE | ID: mdl-26393485

ABSTRACT

Studies have shown that a functional polymorphism of the serotonin transporter gene (5-HTTLPR) impacts performance on memory-related tasks and the hippocampal structures that subserve these tasks. The short (s) allele of 5-HTTLPR has been linked to greater susceptibility for impaired memory and smaller hippocampal volume compared to the long allele (l). However, previous studies have not examined the associations between 5-HTTLPR allele and activation in subregions of the hippocampus. In this study, we used functional magnetic resonance imaging (fMRI) to measure activation in hippocampal and temporal lobe subregions in 36 elderly non-clinical participants performing a face-name encoding and recognition task. Although there were no significant differences in task performance between s allele carriers and l homozygotes, right CA1 and right parahippocampal activation during recognition errors was significantly greater in individuals bearing the s allele. In an exploratory analysis, we determined that these effects were more pronounced in s allele carriers with the apolipoprotein ɛ4 allele. Our results suggest that older individuals with the s allele inefficiently allocate neural resources while making errors in recognizing face-name associations, which could negatively impact memory performance during more challenging tasks.


Subject(s)
Aging/genetics , Hippocampus , Memory Disorders , Serotonin Plasma Membrane Transport Proteins/genetics , Temporal Lobe/physiopathology , Aged , Brain Mapping/methods , Female , Hippocampus/pathology , Hippocampus/physiopathology , Humans , Magnetic Resonance Imaging/methods , Male , Memory/physiology , Memory Disorders/diagnosis , Memory Disorders/genetics , Memory Disorders/physiopathology , Memory Disorders/psychology , Neuropsychological Tests , Organ Size , Polymorphism, Genetic , Task Performance and Analysis
8.
Proc SPIE Int Soc Opt Eng ; 94172015 Feb 21.
Article in English | MEDLINE | ID: mdl-26778878

ABSTRACT

Minimally invasive endovascular image-guided interventions (EIGIs) are the preferred procedures for treatment of a wide range of vascular disorders. Despite benefits including reduced trauma and recovery time, EIGIs have their own challenges. Remote catheter actuation and challenging anatomical morphology may lead to erroneous endovascular device selections, delays or even complications such as vessel injury. EIGI planning using 3D phantoms would allow interventionists to become familiarized with the patient vessel anatomy by first performing the planned treatment on a phantom under standard operating protocols. In this study the optimal workflow to obtain such phantoms from 3D data for interventionist to practice on prior to an actual procedure was investigated. Patient-specific phantoms and phantoms presenting a wide range of challenging geometries were created. Computed Tomographic Angiography (CTA) data was uploaded into a Vitrea 3D station which allows segmentation and resulting stereo-lithographic files to be exported. The files were uploaded using processing software where preloaded vessel structures were included to create a closed-flow vasculature having structural support. The final file was printed, cleaned, connected to a flow loop and placed in an angiographic room for EIGI practice. Various Circle of Willis and cardiac arterial geometries were used. The phantoms were tested for ischemic stroke treatment, distal catheter navigation, aneurysm stenting and cardiac imaging under angiographic guidance. This method should allow for adjustments to treatment plans to be made before the patient is actually in the procedure room and enabling reduced risk of peri-operative complications or delays.

9.
J Obstet Gynaecol ; 33(1): 24-7, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23259873

ABSTRACT

The aim of this research was to compare the accuracy of urinary protein/creatinine ratio (PCR) and albumin/creatinine ratio (ACR) in defining optimal cut-off points to rule-out significant proteinuria (>300 mg/24 h) in pregnancy. The secondary outcome measure was to determine the investigation of choice to evaluate proteinuria used by maternity units in the UK. PCR and ACR were calculated on first (PCR1, ACR1) void urine samples of the 24-hour urinary protein collection (24UP). Sensitivity and specificity was calculated for different cut-off points for PCR1 and ACR1 to rule-out significant proteinuria. An online survey was sent to RCOG members questioning them on their investigation of choice to evaluate proteinuria. We concluded from our results that both PCR and ACR are good rule-out tests for significant proteinuria in pregnancy using cut-off points of <20 mg/mmol and <2.5 mg/mmol. PCR is the investigation of choice in 56% of UK units studied.


Subject(s)
Mass Screening/methods , Pregnancy Complications/diagnosis , Proteinuria/diagnosis , Creatinine/urine , Female , Humans , Pregnancy , Pregnancy Complications/urine , Prospective Studies , Proteinuria/urine , Sensitivity and Specificity
10.
Bioinspir Biomim ; 7(4): 046011, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23093001

ABSTRACT

To properly model the structural dynamics of the forewing of the Manduca sexta species, it is critical that the material and structural properties of the biological specimen be understood. This paper presents the results of a morphological study that has been conducted to identify the material and structural properties of a sample of male and female Manduca sexta specimens. The average mass, area, shape, size and camber of the wing were evaluated using novel measurement techniques. Further emphasis is placed on studying the critical substructures of the wing: venation and membrane. The venation cross section is measured using detailed pathological techniques over the entire venation of the wing. The elastic modulus of the leading edge veins is experimentally determined using advanced non-contact structural dynamic techniques. The membrane elastic modulus is randomly sampled over the entire wing to determine global material properties for the membrane using nanoindentation. The data gathered from this morphological study form the basis for the replication of future finite element structural models and engineered biomimetic wings for use with flapping wing micro air vehicles.


Subject(s)
Aircraft/instrumentation , Biomimetics/instrumentation , Manduca/anatomy & histology , Manduca/physiology , Models, Biological , Wings, Animal/anatomy & histology , Wings, Animal/physiology , Animals , Computer Simulation , Elastic Modulus , Models, Anatomic , Tensile Strength
11.
Mol Psychiatry ; 17(4): 402-11, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21358714

ABSTRACT

Autism spectrum disorders (ASDs) comprise a constellation of highly heritable neuropsychiatric disorders. Genome-wide studies of autistic individuals have implicated numerous minor risk alleles but few common variants, suggesting a complex genetic model with many contributing loci. To assess commonality of biological function among rare risk alleles, we compared functional knowledge of genes overlapping inherited structural variants in idiopathic ASD subjects relative to healthy controls. In this study we show that biological processes associated with synapse function and neurotransmission are significantly enriched, with replication, in ASD subjects versus controls. Analysis of phenotypes observed for mouse models of copy-variant genes established significant and replicated enrichment of observable phenotypes consistent with ASD behaviors. Most functional terms retained significance after excluding previously reported ASD loci. These results implicate several new variants that involve synaptic function and glutamatergic signaling processes as important contributors of ASD pathophysiology and suggest a sizable pool of additional potential ASD risk loci.


Subject(s)
Child Development Disorders, Pervasive/genetics , DNA Copy Number Variations/genetics , Genetic Predisposition to Disease/genetics , Nerve Tissue Proteins/genetics , Synapses/genetics , Synaptic Transmission/genetics , Adolescent , Adult , Animals , Case-Control Studies , Child , Child, Preschool , Female , Genome-Wide Association Study/methods , Genome-Wide Association Study/statistics & numerical data , Genotyping Techniques/methods , Genotyping Techniques/psychology , Humans , Male , Mice , Phenotype
12.
J Alzheimers Dis ; 26 Suppl 3: 331-6, 2011.
Article in English | MEDLINE | ID: mdl-21971472

ABSTRACT

OBJECTIVES: Magnetic Resonance Spectroscopy (MRS) may provide a precise and reliable assessment of the extent and severity of neural tissue loss caused by various diseases. In particular, the N-Acetyl Aspartate (NAA) and Creatine (Cr) ratio has been found to be an indicator of the degree of neuronal loss in Alzheimer's disease (AD). Memantine is thought to benefit the AD brain by stabilizing the NMDA receptors on neurons in turn reducing excitotoxicity. Despite its effectiveness in treating moderate to severe AD, memantine has not had similar success in the treatment of mildly demented AD patients. The objective of this study was to test whether memantine would slow or prevent the loss of neurons in mild to moderate AD patients. METHODS: A double-blind placebo-controlled study was designed to measure the effect of a year-long course of memantine in patients with a probable AD diagnosis with mild to moderate dementia. The primary outcome measure was stipulated to be change in MRS NAA/Cr ratio in inferior parietal cortex in memantine relative to the placebo treatment condition. The secondary outcome measures were changes in cognitive and function scale scores. RESULTS: This pilot study failed to demonstrate a benefit of memantine on the primary outcome measure, the inferior parietal NAA/Cr ratio, or the secondary outcome measures. CONCLUSIONS: More studies are needed to determine the effect of memantine on regions of the brain significantly affected by AD pathology.


Subject(s)
Alzheimer Disease , Excitatory Amino Acid Antagonists/therapeutic use , Magnetic Resonance Spectroscopy , Memantine/therapeutic use , Aged , Aged, 80 and over , Alzheimer Disease/diagnosis , Alzheimer Disease/drug therapy , Alzheimer Disease/metabolism , Aspartic Acid/analogs & derivatives , Aspartic Acid/metabolism , Brain Mapping , Creatine/metabolism , Double-Blind Method , Female , Humans , Longitudinal Studies , Male , Neuropsychological Tests , Pilot Projects
13.
Am J Transplant ; 11(8): 1599-609, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21749640

ABSTRACT

Selective blockade of CD28 is a promising therapy to inhibit pathogenic alloimmunity. However, evaluation of this approach in transplantation has been very limited. Using a novel nonactivating single-chain Fv-based reagent (α28scFv), we have investigated the role of CD28 and cytotoxic T lymphocyte antigen 4 (CTLA-4) in a murine cardiac transplant model. Blockade of CD28 for 2 weeks after engraftment promoted allograft survival, and significantly attenuated chronic rejection when combined with transient CD154-blockade or calcineurin inhibition. Graft acceptance was associated with decreased alloantibody production, increased proportion of early graft infiltration by regulatory T cells and increased expression of regulatory dendritic cell genes. Blockade of CTLA-4 during α28scFv-based treatments led to prompt rejection in all animals and inhibited expression of forkhead box P3 (Foxp3), programmed death (PD)-1 and 2,3-indoleamine dioxygenase (IDO) in the graft. These results show that CD28 signaling during the first weeks after transplant is a pivotal mediator of pathogenic alloimmunity, and that selective CD28 blockade prolongs graft acceptance by at least two immunomodulatory mechanisms. Selective CD28 inhibition while sparing CTLA-4 is thus a promising approach to inhibit pathogenic alloimmunity.


Subject(s)
CD28 Antigens/antagonists & inhibitors , CTLA-4 Antigen/immunology , Heart Transplantation/immunology , Animals , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Lymphocyte Culture Test, Mixed , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Reverse Transcriptase Polymerase Chain Reaction , Transplantation, Homologous
14.
Int J Immunogenet ; 38(4): 287-93, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21382177

ABSTRACT

Systemic juvenile idiopathic arthritis (s-JIA) is a rare inflammatory disease classified as a subtype of chronic childhood arthritis, manifested by spiking fever, erythematous skin rash, pericarditis and hepatosplenomegaly. The genetic background underlying s-JIA remains poorly defined. To detect copy number variations, we performed single nucleotide polymorphism (SNP) array analysis in 50 patients with s-JIA. We found a 13-kb intragenic deletion of CASP10 in one patient. RT-PCR of the mRNA extracted from the patient's lymphoblastoid cells revealed that CASP10 mRNA was truncated. Sequencing the mRNA revealed that this deletion resulted in a frame shift with an early stop codon. CASP10 is known as a causative gene for autoimmune lymphoproliferative syndrome (ALPS) type IIa, another childhood syndrome of lymphadenopathy and splenomegaly associated with autoimmune haemolytic anaemia and thrombocytopenia. TCR αß(+) CD4/CD8 double-negative T cells in the peripheral blood as a diagnostic marker of ALPS were not high in this patient and lymphocyte apoptosis induced by anti-Fas antibody was normal, denying ALPS in the patient. The father and a sister of the patient showing no symptoms of ALPS or s-JIA, also had the same deletion. Furthermore, we found no other mutations of CASP10 in the other 49 s-JIA patients. These data suggest that the pathogenic significance of CASP10 mutations should be carefully evaluated in s-JIA or even ALPS type IIa in further studies.


Subject(s)
Arthritis, Juvenile/genetics , Caspase 10/genetics , Exons/genetics , Sequence Deletion/genetics , Arthritis, Juvenile/immunology , Arthritis, Juvenile/metabolism , Base Sequence , Caspase 8/genetics , Child , Chromosomes, Human, Pair 2 , Female , Gene Order , Genome-Wide Association Study , Humans , Molecular Sequence Data , Pedigree , Polymorphism, Single Nucleotide/genetics , Sequence Alignment , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism
15.
J Nutr Health Aging ; 14(3): 203-6, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20191254

ABSTRACT

Sleep and wake in Alzheimer's disease (AD) are often fragmented as manifested by bouts of wakefulness at night and napping during the day. Management of sleep disturbances in AD is important because of their negative impact on both patients and caregivers. Pharmacological treatments, mainly sedative-hypnotics and antipsychotics, are often used but can be associated with significant adverse effects. Non-pharmacological treatments represent a beneficial alternative approach to the management of sleep disturbances in AD since they are associated with fewer adverse effects and their efficacy can be sustained after treatment has been completed. The aim of this article is to review non-pharmacological treatments, such as sleep hygiene, sleep restriction therapy (SRT), cognitive behavioral therapy (CBT), light therapy, and continuous positive airway pressure (CPAP), for the management of sleep/wake disturbances in AD.


Subject(s)
Alzheimer Disease/complications , Sleep Wake Disorders/therapy , Actigraphy , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Cognitive Behavioral Therapy , Continuous Positive Airway Pressure , Humans , Hygiene , Hypnotics and Sedatives/therapeutic use , Melatonin/therapeutic use , Phototherapy , Sleep Wake Disorders/complications , Sleep Wake Disorders/diagnosis
16.
J Evol Biol ; 23(4): 783-90, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20163506

ABSTRACT

When phenotypic change occurs over time in wildlife populations, it can be difficult to determine to what degree it is because of genetic effects or phenotypic plasticity. Here, we assess phenotypic changes over time in horn length and volume of thinhorn sheep (Ovis dalli) rams from Yukon Territory, Canada. We considered 42 years of horn growth from over 50,000 growth measurements in over 8000 individuals. We found that weather explained a large proportion of the annual fluctuation in horn growth, being particularly sensitive to spring weather. Only 2.5% of variance in horn length growth could be explained by an individual effect, and thus any genetic changes over the time period could only have had a small effect on phenotypes. Our findings allow insight into the capacity for horn morphology to react to selection pressures and demonstrate the overall importance of climate in determining growth.


Subject(s)
Climate Change , Horns/growth & development , Sheep/growth & development , Sheep/physiology , Animals , Ecosystem , Male , Phenotype
17.
J Mater Sci Mater Med ; 21(8): 2299-305, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20094904

ABSTRACT

Calcium phosphate cements have the potential to be successful in minimally invasive surgical techniques, like that of vertebroplasty, due to their ability to be injected into a specific bone cavity. These bone cements set to produce a material similar to that of the natural mineral component in bone. Due to the ceramic nature of these materials they are highly brittle and it has been found that they are difficult to inject. This study was carried out to determine the factors that have the greatest effect on the mechanical and handling properties of an apatitic calcium phosphate cement with the use of a Design of Experiments (DoE) approach. The properties of the cement were predominantly influenced by the liquid:powder ratio and weight percent of di-sodium hydrogen phosphate within the liquid phase. An optimum cement composition was hypothesised and tested. The mechanical properties of the optimised cement were within the clinical range for vertebroplasty, however, the handling properties still require improvement.


Subject(s)
Bone Cements/chemistry , Calcium Phosphates/administration & dosage , Calcium Phosphates/chemistry , Stress, Mechanical , Bone Cements/standards , Calibration , Compressive Strength , Injections/methods , Injections/standards , Materials Testing , Mechanical Phenomena , Microscopy, Electron, Scanning , Particle Size , Specimen Handling/methods , Specimen Handling/standards
18.
Radiat Prot Dosimetry ; 137(1-2): 149-55, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19812127

ABSTRACT

The features of relativistic carbon-ion beams are attractive from the viewpoint of radiotherapy. They exhibit not only a superior physical dose distribution but also an increase in biological efficiency with depth, because energy loss of the beams increases as they penetrate the body. This paper reviews clinical aspects of carbon-beam radiotherapy using the experience at the National Institute of Radiological Sciences. The paper also outlines the dosimetry related to carbon-beam radiotherapy, including absolute dosimetry of the carbon beam, neutron measurements and radiation protection measurements.


Subject(s)
Carbon Radioisotopes/therapeutic use , Neoplasms/radiotherapy , Radiometry , Clinical Trials as Topic , Humans
20.
Biometrics ; 65(1): 275-81, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18479483

ABSTRACT

The analysis of mark-recapture data is undergoing a period of development and expansion. Here we contribute to that by presenting a model which includes both births and immigration, as well as the usual deaths. Data come from a long-term study of the willow tit (Parus montanus), where we can assume that all births are recorded, and hence immigrants can also be identified as birds captured as adults for the first time. We model the rates of immigration, birth rate per parent, and death rates of juveniles and adults. Using a hierarchical model allows us to incorporate annual variation in these parameters. The model is fitted to the data using Markov chain Monte Carlo, as a Bayesian analysis. In addition to the model fitting, we also check several aspects of the model fit, in particular whether survival varies with age or immigrant status, and whether capture probability is affected by previous capture history. The latter check is important, as independence of capture histories is a key assumption that simplifies the model considerably. Here we find that the capture probability depends strongly on whether the individual was captured in the previous year.


Subject(s)
Bayes Theorem , Population Dynamics , Animal Migration , Animals , Birds , Birth Rate , Mortality
SELECTION OF CITATIONS
SEARCH DETAIL
...